Daniela Arzeni

1.0k total citations
38 papers, 796 citations indexed

About

Daniela Arzeni is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Daniela Arzeni has authored 38 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 18 papers in Infectious Diseases and 8 papers in Microbiology. Recurrent topics in Daniela Arzeni's work include Nail Diseases and Treatments (17 papers), Antifungal resistance and susceptibility (17 papers) and Fungal Infections and Studies (15 papers). Daniela Arzeni is often cited by papers focused on Nail Diseases and Treatments (17 papers), Antifungal resistance and susceptibility (17 papers) and Fungal Infections and Studies (15 papers). Daniela Arzeni collaborates with scholars based in Italy, Poland and United States. Daniela Arzeni's co-authors include Giorgio Scalise, Francesco Barchiesi, Luigi Falconi Di Francesco, Andrea Giacometti, Elisabetta Spreghini, Francesca Caselli, Oriana Simonetti, Oscar Cirioni, Daniele Giannini and Anna Maria Offidani and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Daniela Arzeni

37 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Arzeni Italy 18 543 496 150 137 91 38 796
Fernando César Bizerra Brazil 15 568 1.0× 379 0.8× 100 0.7× 246 1.8× 104 1.1× 15 889
M A Ghannoum United States 15 869 1.6× 772 1.6× 74 0.5× 156 1.1× 152 1.7× 15 1.2k
Lucas Pereira de Alencar Brazil 16 387 0.7× 347 0.7× 50 0.3× 150 1.1× 85 0.9× 36 638
Farnaz Daneshnia Netherlands 21 1.1k 2.0× 863 1.7× 63 0.4× 158 1.2× 135 1.5× 40 1.2k
Carlos Eduardo Cordeiro Teixeira Brazil 15 380 0.7× 247 0.5× 54 0.4× 140 1.0× 46 0.5× 24 555
Alvin L. Rogers United States 18 427 0.8× 342 0.7× 56 0.4× 176 1.3× 117 1.3× 30 763
Alba Ruiz‐Gaitán Spain 17 924 1.7× 673 1.4× 42 0.3× 119 0.9× 77 0.8× 39 1.1k
Lisa Lombardi Ireland 16 362 0.7× 273 0.6× 130 0.9× 284 2.1× 35 0.4× 28 725
V. Vidotto Italy 16 463 0.9× 508 1.0× 28 0.2× 158 1.2× 139 1.5× 65 881
G. S. Shankland United Kingdom 18 494 0.9× 540 1.1× 45 0.3× 68 0.5× 237 2.6× 39 884

Countries citing papers authored by Daniela Arzeni

Since Specialization
Citations

This map shows the geographic impact of Daniela Arzeni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Arzeni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Arzeni more than expected).

Fields of papers citing papers by Daniela Arzeni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Arzeni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Arzeni. The network helps show where Daniela Arzeni may publish in the future.

Co-authorship network of co-authors of Daniela Arzeni

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Arzeni. A scholar is included among the top collaborators of Daniela Arzeni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Arzeni. Daniela Arzeni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Savini, Vincenzo, Marijke Hendrickx, Maurizio Sisti, et al.. (2012). An atypical, pigment-producingMetschnikowiastrain from a leukaemia patient. Medical Mycology. 51(4). 438–443. 8 indexed citations
2.
Silvestri, Carmela, Oscar Cirioni, Daniela Arzeni, et al.. (2011). In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. European Journal of Clinical Microbiology & Infectious Diseases. 31(8). 1759–1764. 27 indexed citations
3.
Kamysz, Elżbieta, Oriana Simonetti, Oscar Cirioni, et al.. (2010). In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp.. Peptides. 32(1). 99–103. 13 indexed citations
4.
Barchiesi, Francesco, Carmela Silvestri, Daniela Arzeni, et al.. (2009). In vitrosusceptibility of dermatophytes to conventional and alternative antifungal agents. Medical Mycology. 47(3). 321–326. 25 indexed citations
5.
Simonetti, Oriana, Giulia Ganzetti, Daniela Arzeni, et al.. (2009). In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. Peptides. 30(10). 1794–1797. 14 indexed citations
6.
Simonetti, Oriana, Daniela Arzeni, Giulia Ganzetti, et al.. (2009). In vitroactivity of the lipopeptide derivative (Pal-lys-lys-NH2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. British Journal of Dermatology. 161(2). 249–252. 17 indexed citations
7.
Barchiesi, Francesco, Oscar Cirioni, Daniela Arzeni, et al.. (2007). In-VitroActivity of the Synthetic Protegrin IB-367 Alone and in Combination with Antifungal Agents Against Clinical Isolates ofCandidaspp.. Journal of Chemotherapy. 19(5). 514–518. 9 indexed citations
8.
Barchiesi, Francesco, Andrea Giacometti, Oscar Cirioni, et al.. (2007). In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH2 alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides. 28(8). 1509–1513. 16 indexed citations
9.
Barchiesi, Francesco, et al.. (2006). Effects of Caspofungin against Candida guilliermondii and Candida parapsilosis. Antimicrobial Agents and Chemotherapy. 50(8). 2719–2727. 74 indexed citations
10.
Barchiesi, Francesco, et al.. (2001). In Vitro Activity of Posaconazole against Clinical Isolates of Dermatophytes. Journal of Clinical Microbiology. 39(11). 4208–4209. 44 indexed citations
11.
Barchiesi, Francesco, Daniela Arzeni, Annette W. Fothergill, et al.. (2000). In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens. Antimicrobial Agents and Chemotherapy. 44(1). 226–229. 67 indexed citations
12.
Scalise, Alessandro, Francesco Barchiesi, M. A. Viviani, et al.. (1999). Infection due to Absidia corymbifera in a patient with a massive crush trauma of the foot. Journal of Infection. 38(3). 191–192. 23 indexed citations
13.
Barchiesi, Francesco, et al.. (1999). Electrophoretic Karyotyping and Triazole Susceptibility of Candida glabrata Clinical Isolates. European Journal of Clinical Microbiology & Infectious Diseases. 18(3). 184–187. 16 indexed citations
14.
Barchiesi, Francesco, et al.. (1998). In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. Journal of Antimicrobial Chemotherapy. 41(1). 59–65. 58 indexed citations
15.
Barchiesi, Francesco, et al.. (1998). In vitroactivity of five antifungal agents against clinical isolates ofSaccharomyces cerevisiae. Medical Mycology. 36(6). 437–440. 14 indexed citations
16.
Arzeni, Daniela, Maurizio Del Poeta, Oriana Simonetti, et al.. (1997). Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy. European Journal of Epidemiology. 13(4). 447–450. 27 indexed citations
17.
Barchiesi, Francesco, et al.. (1997). Genotypic identification of sequentialCandida albicans isolates from AIDS patients by polymerase chain reaction techniques. European Journal of Clinical Microbiology & Infectious Diseases. 16(8). 601–605. 28 indexed citations
18.
Poeta, Maurizio Del, et al.. (1994). Comparison of Broth Dilution and Semisolid Agar Dilution forIn VitroSusceptibility Testing ofCryptococcus neoformans. Journal of Chemotherapy. 6(3). 173–176. 3 indexed citations
19.
Poeta, Maurizio Del, et al.. (1994). Turbidimetric and visual criteria for in vitro susceptibility testing of Cryptococcus neoformans clinical isolates. Mycoses. 37(11-12). 411–416. 4 indexed citations
20.
Barchiesi, Francesco, Andrea Giacometti, Daniela Arzeni, et al.. (1992). Fluconazole and Ketoconazole in the Treatment of Oral and Esophageal Candidiasis in AIDS Patients. Journal of Chemotherapy. 4(6). 381–386. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando César Bizerra Breakdown of academic impact, for papers by M A Ghannoum Breakdown of academic impact, for papers by Lucas Pereira de Alencar Breakdown of academic impact, for papers by Farnaz Daneshnia Breakdown of academic impact, for papers by Carlos Eduardo Cordeiro Teixeira Breakdown of academic impact, for papers by Alvin L. Rogers Breakdown of academic impact, for papers by Alba Ruiz‐Gaitán Breakdown of academic impact, for papers by Lisa Lombardi Breakdown of academic impact, for papers by V. Vidotto Breakdown of academic impact, for papers by G. S. Shankland
Rankless by CCL
2026